Relieve the drug shortage! Ningxia key medical supplies producers work overtime to produce urgently needed drugs!

Read Time:5 Minute, 48 Second

In the past few days, in order to effectively respond to the shortage of the region’s antipyretic, analgesic, cough, as well as detoxification, relief of cold and flu symptoms and other effects of the current situation, the region’s multi-measures to ensure the production and supply of key medical supplies.

“Our region’s existing Qiyuan Guohua, Dovetail Pharmaceuticals and Golden Sun Pharmaceuticals 3 Chinese patent medicine manufacturers can produce 38 kinds of drugs with the efficacy of antipyretic, analgesic, cough and clearing fever and relieving cold symptoms.” The relevant person in charge of the Department of Industry and Information Technology of the autonomous region, the Department has held a mobilization meeting on December 12, requiring enterprises to produce at full capacity and prepare for the replacement of real estate drugs. As of December 24, a total of 8 varieties of drugs have been produced more than 920,000 boxes / (bags, bottles), 22 varieties of inventory of nearly 900,000 boxes / (bags, bottles).

According to statistics, as of December 24, the region’s medical institutions four types of drugs in stock more than 81,000 boxes / bottles, drug wholesale and retail enterprises inventory of more than 600,000 boxes / bottles, three proprietary Chinese medicine manufacturers have real estate 33 types of anti-fever and cough alternative drugs more than 1.03 million boxes / bottles.

In order to effectively respond to the “four types” of drug supply shortage in the region, the autonomous region of industry and information technology department emergency mapping of the “four types” of drug sales, procurement, reserves, production and other situations, and actively coordinate with the State Ministry of Industry and Information Technology to allocate scarce supplies. By the 24th, the Ministry of Industry and Information Technology applied for the allocation of 20 million copies of antigen detection reagents, 1.9 million boxes of drugs and 34,000 kg of raw materials for antipyretic and analgesic drugs. The Ministry of Industry and Information Technology from Guangdong 6 million copies of antigen detection reagents have arrived on the 20th, from Hebei Ealing Pharmaceuticals 300,000 boxes of Lianhua Qingfei granules have arrived in the afternoon of the 24th, other drugs and raw materials are being coordinated in the implementation.

In addition, in accordance with the unified arrangement of the Ministry of Industry and Information Technology, our region actively docked with Beijing Jingdong Health Company, the afternoon of December 24 has opened in the Jingdong shopping platform “Ningxia key drugs across the region precise placement platform”, directed to our region precise placement of a number of antipyretic and analgesic drugs, timely relief of the masses with drug needs, to 9:00 a.m. on the 25th, the platform has to By 9:00 a.m. on the 25th, the platform had sold 75026 boxes of Lianhua Qingfei and 5512 boxes of N95 masks (20 per box) to patients in our region.

At present, the key medical supplies manufacturers in our region to find ways to coordinate raw materials, working overtime to produce urgent drugs.　
On December 25, the reporter saw in the production workshop of Ningxia Dovey Pharmaceutical Co., Ltd. that the various production lines have been running at full capacity, and the employees have continued to produce 24 hours a day in three shifts, and many of them have not been home for nearly a month or two.

“The company produces eight drugs such as Sanchen San, Wu Wei Musk Pills, Fifteen Flavors Gentian Flower Pills, Xuanmai Ganghuang Granules and Anti-sensitive Capsules have been included in the ‘New Coronavirus Infection Symptomatic Treatment Drug Catalogue (Ningxia Real Estate Drugs)’.” The company’s general manager Chen Degang introduced that, according to the clinical treatment experience, the Sanchen San, Wu Wei Musk Pills, Fifteen Flavors Gentian Flower Pills and Xuanmai Ganqiang Orange Granules produced by Dovetail Pharmaceutical have therapeutic effect on the symptoms related to the new coronavirus infection. Among them, Sanchen San has positive efficacy in treating high fever and fever in children.

At present, the monthly production volume of “Sanchen San” is 100,000 boxes; the monthly production volume of “Wu Wei Musk Pill”, which is suitable for influenza and various pains and inflammations, is 200,000 boxes; and the monthly production volume of “Fifteen Flavors Gentian Flower Pill”, which treats cough and asthma, acute and chronic bronchitis, etc. The monthly production volume of “Fifteen Flavors Gentian Flower Pill” is 150,000 boxes; the monthly production volume of Xuanmai Ganghuang Granules, which can clear heat and nourish Yin, dispel phlegm and benefit the throat, is 50,000 boxes.

On December 17, Ningxia Qiyuan National Pharmaceutical Co., Ltd. resumed production of ibuprofen tablets, an antipyretic and analgesic drug, with more than 100 employees working in three shifts in the factory for 24-hour non-stop production. The daily output of Jinlian Qinghe granules is 36,000 bags, and the daily output of Vitamin C silver warp tablets is 500,000 tablets.

On December 25, in Ningxia Golden Sun Pharmaceutical Co., the four production lines of Shuangxin Sinusitis Granules, Pharyngitis Containing Tablets, Vitamin C Yinjiao Tablets and Banlangen Granules worked overtime and ran at full capacity.

“From October until now there has been no rest.” Zhang Junlong, the relevant person in charge of the company, introduced that in order to protect the market demand of key medical supplies, the company has increased the planned output of 30 million tablets of pharyngitis tablets and 19.6 million tablets of vitamin C silver warp tablets, and currently the daily output of vitamin C silver warp tablets is 1.6 million tablets, the daily output of pharyngitis tablets is 900,000 tablets, and the daily production of plate bluegan granules is 80,000 bags.

“We plan not to take a break on New Year’s Day and work overtime to keep the supply at full capacity.” Zhang Junlong said.

Ningxia Yuetai Technology Development Co., Ltd. has put more than 3 million N95 masks into the Ningxia market since the end of November until now, with a current daily output of 600,000.

Ningxia Kyushu Tong Pharmaceutical Co., Ltd. took the initiative to dock with Ealing Pharmaceutical and other enterprises to coordinate more than 500,000 boxes of Lianhua Qingfei capsules, which are currently being shipped to the Ningxia market.

At present, from outside the region for the treatment of new coronavirus infection fever, cough, antiviral, antibiotics and other “four types” of drugs are being stepped up transport to Ningxia.

“We are in accordance with the unified deployment of autonomous regions, and actively seek the support of the national joint prevention and control mechanism of medical supplies, continue to do a good job in the production of key pharmaceutical manufacturers in the region to ensure the production of drugs, raw materials and other important medical supplies from outside the region to ensure that the region’s new coronavirus infected with the demand for drugs.” Autonomous Region of Industry and Information Technology Department, said the relevant person in charge.